Stocks / NASDAQ / Peregrine Pharmaceuticals Inc.

Peregrine Pharmaceuticals Inc.

Our Opinion

Peregrine Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing and commercializing of some of their pharmaceutical products.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“Just last month, we announced results from another preclinical study in TNBC demonstrating that 80% of animals receiving the triple combination of anti-PS, anti-PD-1 and anti-LAG3 therapies experienced complete tumor regressions, whereas there were no animals in the anti-PD-1 and anti-LAG3 combination treatment arm that had a complete regression,” said Jeff T. Hutchins, Ph.D., Peregrine’s vice president, preclinical research.” Read the following article

Company Description

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the provision of monoclonal antibody therapeutics. It operates through Peregrine and Avid segments. The Peregrine segment refers to research and development of monoclonal antibodies for the treatment and diagnosis of cancer. The Avid segment provides contract management services for peregrine and third-party customers on a fee-for-services basis.
[Source: MarketWatch]

Company Website: